Is a complete ABVC research report available?

No complete published report is available for ABVC BioPharma, Inc. (ABVC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ABVC BioPharma, Inc. (ABVC)

NASDAQ: ABVC · USD

$1.15

-0.05 (-4.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ABVC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	29.1M
Net income (ttm)	-8.6M
EPS (ttm)	-$0.38
Shares out	25.3M
Volume	84,434
Beta	0.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -8.6M
EPS (ttm): -$0.38
Market cap: 29.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ABVC indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001173313
Company name	ABVC BioPharma, Inc.
Country	United States
Country code	US
Cusip	00091F304
Employees	19
Employees Change	-4%
Employees Change Percent	-17.39
Enterprise value	$31.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US00091F3047
Last refreshed	2026-07-25
Market cap	$29.1M
Market cap category	Nano-Cap
Price	$1.15
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	ABVC
Website	https://www.abvcpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-29.69%
FCF yield	-11.5%
P/B ratio	2.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-8.6M
Net Income Growth Years	0%
Profit Per Employee	$-454,038
ROA	-29.01
Roa5y	-51.47
ROCE	-56
ROE	-87.78
Roe5y	-299.7
ROIC	-38.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-43.71%
Cagr15y	-0.14%
Cagr1y	-62.57%
Cagr20y	-19.53%
Cagr3y	-32.86%
Cagr5y	-52.88%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$19.7M
Cash	$202,509
Current Assets	$648,848
Current Liabilities	$5.4M
Debt	$2.7M
Debt Equity	$0.21
Equity	$12.8M
Interest Coverage	-33.14
Liabilities	$6.9M
Long Term Assets	$19.1M
Long Term Liabilities	$1.5M
Net Cash	$-2.5M
Net Cash By Market Cap	$-8.7
Net Debt Equity	$0.2
Tangible Book Value	$10.8M
Tangible Book Value Per Share	$0.43
WACC	7.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.12
Net Working Capital	$-3.7M
Quick ratio	0.04
Working Capital	$-4.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-75.08%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.68%
1Y total return	-62.54%
200-day SMA	1.81
3Y total return	-69.74%
50-day SMA	1.35
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.68%
All Time High	1,432.7
All Time High Change	-99.92%
All Time High Date	2015-09-17
All Time Low	0.06
All Time Low Change	1,906.98%
All Time Low Date	2013-12-05
ATR	0.14
Beta	0.54
Beta1y	2.08
Beta2y	1.69
Ch YTD	-46.01
High	1.21
High52	3.4
High52 Date	2025-10-07
High52ch	-66.18%
Low	1.15
Low52	0.88
Low52 Date	2026-03-30
Low52ch	30.67%
Ma50ch	-14.94%
Premarket Change Percent	0.83
Premarket Price	$1.21
Premarket Volume	1,454
Price vs 200-day SMA	-36.53%
RSI	38.32
RSI Monthly	37.85
RSI Weekly	41.25
Sharpe ratio	-0.74x
Sortino ratio	-0.97
Total Return	-75.08%
Tr YTD	-46.01
Tr15y	-2.11%
Tr1m	-12.21%
Tr1w	-8%
Tr3m	0.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-8M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,441,681%
Float Percent	80.89%
Net Borrowing	-291,074
Shares Insiders	18.86%
Shares Institutions	3.26%
Shares Out	25,269,801
Shares Qo Q	2.89%
Shares Yo Y	75.08%
Short Float	1.79%
Short Ratio	2.54
Short Shares	1.45

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.2M
Average Volume	184,202.45x
Bv Per Share	0.43
Ch10y	-99.68
Ch15y	-2.13
Ch1m	-12.21
Ch1w	-8
Ch1y	-62.54
Ch20y	-98.71
Ch3m	0.88
Ch3y	-69.74
Ch5y	-97.68
Ch6m	-44.17
Change	-4.17%
Change From Open	-4.17
Close	1.2
Days Gap	0
Depreciation Amortization	24,092
Dollar Volume	97,099.1
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-8M
EBITDA	$-8M
EPS	$-0.38
F Score	1
FCF	$-3.3M
FCF EV Yield	-10.58x
FCF Per Share	$-0.13
Financing CF	3,867,058
Fiscal Year End	December
Founded	2,015
Income Tax	$24,154
Investing CF	-1,161,667
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-18
Last Report Date	2026-03-31
Last Split Date	2023-07-25
Last Split Type	Reverse
Last10k Filing Date	2026-03-03
Ma150	1.5
Ma150ch	-23.38%
Ma20	1.48
Ma20ch	-22.14%
Net CF	-619,244
Next Earnings Date	2026-08-12
Open	1.2
Optionable	Yes
Position In Range	0
Post Close	1.15
Postmarket Change Percent	0.43
Postmarket Price	$1.16
Ppne	14,649,890
Pre Close	1.2
Price Date	2026-07-24
Ptbv Ratio	2.7
Relative Volume	0.46x
Share Based Comp	4,881,417
Tr20y	-98.71%
Tr6m	-44.17%
Us State	California
Volume	84,434

ABVC BioPharma, Inc. (ABVC)

Coverage state: Market snapshot only — no published research

Generate the first ABVC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ABVC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ABVC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ABVC

Frequently asked questions